Vanguard Group’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.5M | Buy |
2,477,502
+525,169
| +27% | +$3.29M | ﹤0.01% | 2680 |
|
|
2025
Q1 | $11.4M | Buy |
1,952,333
+34,603
| +2% | +$203K | ﹤0.01% | 2768 |
|
|
2024
Q4 | $15.8M | Buy |
1,917,730
+112,296
| +6% | +$923K | ﹤0.01% | 2702 |
|
|
2024
Q3 | $16.1M | Buy |
1,805,434
+38,024
| +2% | +$339K | ﹤0.01% | 2707 |
|
|
2024
Q2 | $13.4M | Buy |
1,767,410
+80,000
| +5% | +$605K | ﹤0.01% | 2760 |
|
|
2024
Q1 | $13.2M | Sell |
1,687,410
-43,021
| -2% | -$338K | ﹤0.01% | 2806 |
|
|
2023
Q4 | $15.3M | Buy |
1,730,431
+699,337
| +68% | +$6.2M | ﹤0.01% | 2713 |
|
|
2023
Q3 | $9.25M | Buy |
1,031,094
+2,922
| +0.3% | +$26.2K | ﹤0.01% | 2932 |
|
|
2023
Q2 | $12.7M | Sell |
1,028,172
-20,415
| -2% | -$252K | ﹤0.01% | 2813 |
|
|
2023
Q1 | $9.73M | Buy |
1,048,587
+185,007
| +21% | +$1.72M | ﹤0.01% | 2949 |
|
|
2022
Q4 | $9.07M | Buy |
863,580
+257,696
| +43% | +$2.71M | ﹤0.01% | 2995 |
|
|
2022
Q3 | $11M | Buy |
605,884
+170,709
| +39% | +$3.09M | ﹤0.01% | 2917 |
|
|
2022
Q2 | $6.17M | Buy |
435,175
+206,542
| +90% | +$2.93M | ﹤0.01% | 3260 |
|
|
2022
Q1 | $5.03M | Buy |
228,633
+2,375
| +1% | +$52.3K | ﹤0.01% | 3526 |
|
|
2021
Q4 | $3.84M | Buy |
+226,258
| New | +$3.84M | ﹤0.01% | 3756 |
|